Advertisement

Comparison of clinical outcome, cartilage turnover, and inflammatory activity following either intra-articular or a combination of intra-articular with intra-osseous platelet-rich plasma injections in osteoarthritis knee: A randomized, clinical trial

Published:November 14, 2022DOI:https://doi.org/10.1016/j.injury.2022.11.036

      Highlights

      • IA-PRP injections are common treatments for knee OA.
      • IA+IO-PRP injection provides better pain relief and functional improvement at 12-weeks.
      • IA-PRP and IA+IO-PRP injections reduce inflammatory markers (ESR and CRP) at 12-weeks.
      • IA-PRP and IA+IO-PRP PRP injections reduce u-CTX-II levels at 12-weeks.
      • IA+IO-PRP injection reduces u-NTX-I level at 12-weeks.

      Abstract

      Background

      The objective of the study was to determine the changes in clinical outcome (pain and knee activity) and assess bone/ cartilage biomarkers and inflammatory activity in persons with osteoarthritis (OA) knee following a single injection of intra-articular platelet-rich plasma (IA-PRP) and combination of intra-articular, intraosseous PRP (IA+IO-PRP).

      Methods

      This prospective, randomized, single-blind clinical trial was conducted at a tertiary care teaching hospital in India. Ninety-six persons with OA knee with a Kellgren-Lawrence score of 3 were randomized into three groups- Group-I (IA-PRP), Group-II (IA+IO-PRP)], Group-III, [intra-articular normal saline (IA-NS)]. The primary outcome was a visual analog scale (VAS) for pain. The secondary outcomes were the Knee Injury and Osteoarthritis Outcome Score (KOOS), erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), bone/ cartilage turnover biomarkers [C-telopeptide (CTX-II), N-telopeptide (NTX-I), cartilage oligomeric matrix protein (COMP), N-terminal propeptide of collagen type-IIA (PIIANP), and hyaluronic acid (HA)], ultrasonography (USG) findings of the knee joint. The outcome measures were assessed at baseline, 6, and 12 weeks of follow-up.

      Results

      Compared to IA-NS injection, IA-PRP and IA+IO-PRP injections significantly improved VAS-pain and KOOS scores at 6 and 12 weeks. Furthermore, both PRP groups showed a significant reduction in ESR, CRP, and CTX-II at 12 weeks following PRP injections. In addition, at 12 weeks, the IA+IO-PRP group showed a significant reduction (p=0.009) in NTX-I level. Persons in the IA+IO-PRP group reported significant reductions in the synovial-effusion and infra-patellar bursitis.

      Conclusions

      Significant clinical improvements were noticed following IA-PRP and IA-IO-PRP injections compared to IA-NS injections. Both PRP groups reported a significant reduction in ESR, CRP, and CTX-II levels at 12 weeks. Persons in the IA+IO-PRP group reported significant changes in u-NTX-I level and knee-USG findings.

      Keywords

      Abbreviations:

      ADL (Activities of daily living), COMP (Cartilage oligomeric matrix protein), CTX-II (C-telopeptides of type-II collagen), CRP (C-reactive protein), ESR (Erythrocyte sedimentation rate), HA (Hyaluronic acid), IA-PRP (Intra-articular platelet-rich plasma), IA+IO (PRP –Intra-articular and intra-osseous platelet-rich plasma), KOOS (Knee Injury and Osteoarthritis Outcome Score), NTX-I (N-telopeptides of type-I collagen), PIIANP (N-terminal propeptide of collagen type-IIA), OA (Osteoarthritis), PRP (Platelet-rich plasma), QoL (Quality of life), RCTs (Randomized controlled trials), VAS (Visual analog scale)
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Injury
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Mobasheri A
        • Batt M.
        An update on the pathophysiology of osteoarthritis.
        Ann Phys Rehabil Med. 2016; 59: 333-339
        • Singh V
        • Oliashirazi A
        • Tan T
        • Fayyad A
        • Shahi A.
        Clinical and pathophysiologic significance of MRI identified bone marrow lesions associated with knee osteoarthritis.
        Arch Bone Jt Surg. 2019; 7: 211-219
        • Felson DT
        • McLaughlin S
        • Goggins J
        • LaValley MP
        • Gale ME
        • Totterman S
        • et al.
        Bone marrow edema and its relation to progression of knee osteoarthritis.
        Ann Intern Med. 2003; 139: 330-336
        • Pan J
        • Wang B
        • Li W
        • Zhou X
        • Scherr T
        • Yang Y
        • et al.
        Elevated cross-talk between subchondral bone and cartilage in osteoarthritic joints.
        Bone. 2012; 51: 212-217
        • Barr AJ
        • Campbell TM
        • Hopkinson D
        • Kingsbury SR
        • Bowes MA
        • Conaghan PG.
        A systematic review of the relationship between subchondral bone features, pain and structural pathology in peripheral joint osteoarthritis.
        Arthritis Res Ther. 2015; 17: 228
        • Sánchez M
        • Delgado D
        • Sánchez P
        • Muiños-López E
        • Paiva B
        • Granero-Moltó F
        • et al.
        Combination of intra-articular and intraosseous injections of platelet rich plasma for severe knee osteoarthritis: a pilot study.
        BioMed Res Int. 2016; 20164868613
        • Everts P
        • Onishi K
        • Jayaram P
        • Lana JF
        • Mautner K.
        Platelet-rich plasma: new performance understandings and therapeutic considerations in 2020.
        Int J Mol Sci. 2020; 21: 7794
        • Filardo G
        • Previtali D
        • Napoli F
        • Candrian C
        • Zaffagnini S
        • Grassi A.
        PRP injections for the treatment of knee osteoarthritis: a meta-analysis of randomized controlled trials.
        Cartilage. 2021; 13: 364S-375S
        • Louis ML
        • Magalon J
        • Jouve E
        • Bornet CE
        • Mattei JC
        • Chagnaud C
        • et al.
        Growth factors levels determine efficacy of platelets rich plasma injection in knee osteoarthritis: a randomized double blind noninferiority trial compared with viscosupplementation.
        Arthrosc J Arthrosc Relat Surg Off Publ Arthrosc Assoc N Am Int Arthrosc Assoc. 2018; 34 (e2): 1530-1540
        • Patel S
        • Dhillon MS
        • Aggarwal S
        • Marwaha N
        • Jain A.
        Treatment with platelet-rich plasma is more effective than placebo for knee osteoarthritis: a prospective, double-blind, randomized trial.
        Am J Sports Med. 2013; 41: 356-364
        • Anitua E
        • Sánchez M
        • Aguirre JJ
        • Prado R
        • Padilla S
        • Orive G.
        Efficacy and safety of plasma rich in growth factors intra-articular infiltrations in the treatment of knee osteoarthritis.
        Arthrosc J Arthrosc Relat Surg Off Publ Arthrosc Assoc N Am Int Arthrosc Assoc. 2014; 30: 1006-1017
        • Jang SJ
        • Kim JD
        • Cha SS.
        Platelet-rich plasma (PRP) injections as an effective treatment for early osteoarthritis.
        Eur J Orthop Surg Traumatol Orthop Traumatol. 2013; 23: 573-580
        • Bennell KL
        • Paterson KL
        • Metcalf BR
        • Duong V
        • Eyles J
        • Kasza J
        • et al.
        Effect of intra-articular platelet-rich plasma vs placebo injection on pain and medial tibial cartilage volume in patients with knee osteoarthritis: the restore randomized clinical trial.
        JAMA. 2021; 326: 2021-2030
        • Goldring MB
        • Otero M.
        Inflammation in osteoarthritis.
        Curr Opin Rheumatol. 2011; 23: 471-478
        • Hanada M
        • Takahashi M
        • Furuhashi H
        • Koyama H
        • Matsuyama Y.
        Elevated erythrocyte sedimentation rate and high-sensitivity C-reactive protein in osteoarthritis of the knee: relationship with clinical findings and radiographic severity.
        Ann Clin Biochem. 2016; 53: 548-553
        • Pearle A
        • Scanzello C
        • George S
        • Mandl L
        • DiCarlo E
        • Peterson M
        • et al.
        Elevated high-sensitivity C-reactive protein levels are associated with local inflammatory findings in patients with osteoarthritis - ClinicalKey.
        Osteoarthritis Cartilage. 2007; 15: 516-523
        • Sellam J
        • Berenbaum F.
        The role of synovitis in pathophysiology and clinical symptoms of osteoarthritis.
        Nat Rev Rheumatol. 2010; 6: 625-635
        • Saberi Hosnijeh F
        • Siebuhr AS
        • Uitterlinden AG
        • Oei EHG
        • Hofman A
        • Karsdal MA
        • et al.
        Association between biomarkers of tissue inflammation and progression of osteoarthritis: evidence from the Rotterdam study cohort.
        Arthritis Res Ther. 2016; 18 ([cited 2019 Feb 22]Available from)
        • Mobasheri A
        • Bay-Jensen AC
        • van Spil WE
        • Larkin J
        • Levesque MC.
        Osteoarthritis year in review 2016: biomarkers (biochemical markers).
        Osteoarthritis Cartilage. 2017; 25: 199-208
        • Klocke R
        • Levasseur K
        • Kitas GD
        • Smith JP
        • Hirsch G.
        Cartilage turnover and intra-articular corticosteroid injections in knee osteoarthritis.
        Rheumatol Int. 2018; 38: 455-459
        • Elliott AL
        • Kraus VB
        • Luta G
        • Stabler T
        • Renner JB
        • Woodard J
        • et al.
        Serum hyaluronan levels and radiographic knee and hip osteoarthritis in African Americans and Caucasians in the Johnston County Osteoarthritis Project.
        Arthritis Rheum. 2005; 52: 105-111
        • Sasaki E
        • Tsuda E
        • Yamamoto Y
        • Maeda S
        • Inoue R
        • Chiba D
        • et al.
        Serum hyaluronic acid concentration predicts the progression of joint space narrowing in normal knees and established knee osteoarthritis - a five-year prospective cohort study.
        Arthritis Res Ther. 2015; 17: 283
        • Bevers K
        • Bijlsma JWJ
        • Vriezekolk JE
        • van den Ende CHM
        • den Broeder AA.
        The course of ultrasonographic abnormalities in knee osteoarthritis: 1 year follow up.
        Osteoarthritis Cartilage. 2014; 22: 1651-1656
        • Bevers K
        • Zweers MC
        • van den Ende CHM
        • Martens HA
        • Mahler E
        • Bijlsma JWJ
        • et al.
        Ultrasonographic analysis in knee osteoarthritis: evaluation of inter-observer reliability.
        Clin Exp Rheumatol. 2012; 30: 673-678
        • Sánchez M
        • Delgado D
        • Pompei O
        • Pérez JC
        • Sánchez P
        • Garate A
        • et al.
        Treating severe knee osteoarthritis with combination of intra-osseous and intra-articular infiltrations of platelet-rich plasma: an observational study.
        Cartilage. 2019; 10: 245-253
        • Delgado D
        • Garate A
        • Vincent H
        • Bilbao AM
        • Patel R
        • Fiz N
        • Sampson S
        • Sánchez M.
        Current concepts in intraosseous platelet-rich plasma injections for knee osteoarthritis.
        J Clin Orthop Trauma. 2019; 10: 36-41
        • Mishra A
        • Harmon K
        • Woodall J
        • Vieira A.
        Sports medicine applications of platelet rich plasma.
        Curr Pharm Biotechnol. 2012; 13: 1185-1195
        • Jm D
        • Rp R
        • Ad M.
        Platelet-rich plasma: the PAW classification system.
        Arthrosc J Arthrosc Relat Surg Off Publ Arthrosc Assoc N Am Int Arthrosc Assoc. 2012; 28 ([cited 2022 Jun 6]Available from:)
        • Kuculmez O
        • Şirin F
        • Sarikaya N
        • Kocyigit H.
        Effect of platelet-rich plasma on serum and urine biomarkers in patients with knee osteoarthritis.
        Int J Clin Exp Med. 2020; 13: 5040-5049
        • Barman A
        • Prakash S
        • Sahoo J
        • Mukherjee S
        • Maiti R
        • Roy SS.
        Single intra-articular injection with or without intra-osseous injections of platelet-rich plasma in the treatment of osteoarthritis knee: a single-blind, randomized clinical trial.
        Injury. 2022; 53: 1247-1253
        • Lychagin A
        • Lipina M
        • Garkavi A
        • Islaieh O
        • Timashev P
        • Ashmore K
        • Kon E.
        Intraosseous injections of platelet rich plasma for knee bone marrow lesions treatment: one year follow-up.
        Int Orthop. 2021; 45: 355-363
        • Centeno C
        • Cartier C
        • Stemper I
        • Dodson E
        • Freeman M
        • Azuike U
        • et al.
        The treatment of bone marrow lesions associated with advanced knee osteoarthritis: comparing intraosseous and intraarticular injections with bone marrow concentrate and platelet products.
        Pain Physician. 2021; 24: E279-E288
        • Zhang J
        • Middleton KK
        • Fu FH
        • Im HJ
        • Wang JHC.
        HGF mediates the anti-inflammatory effects of PRP on injured tendons.
        PLoS ONE. 2013; 8: e67303
        • Xu Z
        • Yin W
        • Zhang Y
        • Qi X
        • Chen Y
        • Xie X
        • et al.
        Comparative evaluation of leukocyte- and platelet-rich plasma and pure platelet-rich plasma for cartilage regeneration.
        Sci Rep. 2017; 7 (07): 43301
        • Keen HI
        • Wakefield RJ
        • Conaghan PG.
        A systematic review of ultrasonography in osteoarthritis.
        Ann Rheum Dis. 2009; 68: 611-619